In recent months, Eli Lilly, the maker of Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy, have each said that they are able to meet the demand for the medications after facing shortages since 2022 due to the drugs' growing popularity
We break down the process of achieving your ideal body into simple daily habits to make this doable and enjoyable for you
Role of Transcription Factor NRF2 in Oxidative Stress Responses A major response to the accumulation of reactive oxidants, such as ROS and RNS, is the activation of a transcription factor identified as NRF2 [nuclear factor erythroid 2 (NFE2)related factor 2]
Tirzepatide: Nausea and vomiting during dose escalation Fatigue and occasional hypoglycemia (especially if combined with insulin or sulfonylureas) Potential risk of gallbladder issues due to rapid weight loss Cagrilintide: Mild nausea in first two weeks Occasional constipation or reduced appetite beyond comfort No significant hypoglycemia risk Both should be avoided during pregnancy, breastfeeding, or by individuals with personal/family history of medullary thyroid carcinoma (a class precaution for incretin-based therapies)
